Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1853)	12/6/2001 12:40:48 PM
From: Rocketman	Respond to of 3202

diaDexus, this is a company that has been a big disappointment to me. Too pharma like, they take forever to get anything done, and now that they have something hot, they dump it off and dilute the value chain. I heard rumors about this colorectal stuff about 2 years ago. Let's get the damn test out the door and into the clinics, this is a diagnostic, it doesn't have to be perfect, just good enough. Look how unreliable the existing stuff is. These guys have "pharma disease" they are just too damned conservative to move fast. Maybe it is better that they dump it off to some one else who won't take forever to get it to market. Rman